Explicit Approach for Language Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different teaching methods can help children with developmental language disorder (DLD) improve their grammar. Participants will receive either a combination of explicit (direct) and implicit (indirect) teaching, known as the Explicit-added treatment, or just implicit teaching, referred to as the Implicit-only treatment, to determine which is more effective. The goal is to identify which approach best helps children with DLD learn and maintain better grammatical skills over time. The study seeks children aged 5 to 9 years who have significant trouble using grammar but do not have other conditions like autism or hearing problems. As an unphased trial, this study offers a unique opportunity to contribute to educational research that could benefit children with DLD worldwide.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that specific language teaching methods can be effective and safe for children with developmental language disorders (DLD). Studies comparing direct teaching (explicit) and indirect learning (implicit) found that children learned and remembered grammar better with direct teaching.
In indirect learning, children acquire language skills without full awareness. Research on this method has produced mixed results; some studies found it helpful, while others did not observe significant improvement in language skills.
Both direct and indirect methods have been studied and are generally well-received by children. No major safety concerns have been reported for either method, suggesting both approaches are safe options for helping children with DLD improve their language skills.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores different techniques to tackle language disorders, focusing on both implicit and explicit methods. Unlike traditional therapies that may rely heavily on one type of treatment approach, this trial investigates how a combination of implicit and explicit treatments might improve outcomes. By tailoring the treatment based on a patient's mastery of skills, this study aims to discover a more personalized and potentially more effective way to manage language disorders. The goal is to find out if mixing these methods can accelerate progress and provide better, longer-lasting results for people with language challenges.
What evidence suggests that this trial's treatments could be effective for developmental language disorder?
Research has shown that both direct and indirect teaching methods can improve language skills in children with developmental language disorder (DLD). In this trial, participants may receive either the Explicit-added treatment or the Implicit-only treatment. Studies have found that combining these methods enhances children's understanding of grammar, which is often challenging for those with DLD. One review found that direct teaching led to significant progress in both speaking and understanding language. In contrast, methods relying solely on natural language exposure might not yield as much improvement. Evidence suggests that direct methods provide stronger support for children struggling with grammar. Overall, the data supports the idea that using both methods together could be more beneficial than using only indirect methods.26789
Are You a Good Fit for This Trial?
This trial is for English-speaking children aged 5-9 with developmental language disorder (DLD) and grammatical weaknesses. They must be native English speakers, have typical hearing and vision (with correction if needed), and not have conditions like autism or Down syndrome that could explain their language issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Phase 1 Treatment
Participants are randomized to either Explicit-added or Implicit-only treatment groups, completing 32 sessions targeting grammatical forms
Phase 2 Treatment
Participants are re-randomized based on mastery level to receive additional treatment sessions or no further treatment
Follow-up
Participants are monitored for acquisition, maintenance, and generalization of grammatical forms post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Explicit-added
- Implicit-only
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor